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Aim: Sternal intramedullary bleeding is an important contributor to postcardiac surgery hemorrhage. The aim of this study is to
investigate the effects of bone wax, oxidized regenerated cellulose, and electrocoagulation on sternal intramedullary hemostatic control.
Materials and methods: A total of 142 patients undergoing on-pump coronary bypass surgery were prospectively studied. The patients
were randomized into 3 groups; bone wax concomitant with electrocauterization, oxidized regenerated cellulose concomitant with
electrocauterization, and electrocauterization alone. The amount of postoperative hemorrhage was noted at the 1st, 2nd, 3rd, 6th, 12th
and 24th hours. Rates of reexploration for hemorrhage and number of units of blood and its products used were also studied.
Results: The mean age of the patients was 64.23 ± 5.81 years. There were 114 (79.7%) male patients. The patients were comparable
regarding preoperative demographics except age and intraoperative variables. The amount of postoperative hemorrhage was lowest
in the oxidized regenerated cellulose and highest in the electrocauterization alone group. The number of fresh frozen plasma and
erythrocyte suspension used was also lowest in the oxidized regenerated cellulose group.
Conclusion: To overcome hemorrhage originating from the sternal intramedullary space, oxidized regenerated cellulose use concomitant
with electrocauterization is effective and can be safely used immediately before closing the chest in open heart surgery.
Key words: Sternum, hemorrhage, electrocoagulation, cellulose, oxidized, bone wax

1. Introduction
Postoperative bleeding is still one of the most important
issues following open heart surgery. The reexploration
rate for hemorrhage was reported as between 2% and
6% following coronary artery bypass grafting (CABG)
(1). Surgical and hematological etiologies should be
distinguished to give an exact decision for reexploration.
Multiple surgical sites may cause bleeding, including distal
and proximal anastomoses, cannulation sites, branches
of arterial and venous grafts, the internal thoracic wall
where the internal mammary artery is harvested, anterior
mediastinum, and others. Postoperative bleeding results
in increased mortality and morbidity rates and health care
costs (2). Excessive blood loss requiring heavy transfusion
is also a well-known risk factor for wound infections and
* Correspondence: barisdurukan@yahoo.com

subsequent sternal dehiscence (3). During the healing
process in the sternotomy incision site, a spectrum of
complications from simple seromas to dehiscence of
all layers with instability of the thoracic wall and severe
osteomyelitis, purulent pericarditis, and mediastinitis may
occur (3). Some hemorrhage may result from the sternal
intramedullary area. In this clinical study, we aimed to
emphasize the importance of intramedullary bleeding
control while comparing different management strategies.
2. Materials and methods
A prospective, controlled, and randomized study was carried
out. The study was approved by the local ethics committee, and
written informed consent was obtained from every patient.
From January 2010 to December 2011, 252 on-pump CABG
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operations were performed in a single center. The patients
were randomized into 3 groups according to chronological
order. The first group received bone wax (Bone-wax®,
Aesculap Inc., USA) concomitant with electrocauterization,
the second group received oxidized regenerated cellulose
(ORC) (Surgicel® Absorbable Hemostat, Johnson & Johnson,
Ethicon Inc., USA) concomitant with electrocauterization,
and electrocauterization alone was performed in the third
group.
All anticoagulant and antiplatelet medications were
stopped 1 week prior to the surgery. Preoperative and
postoperative routine coagulation tests including activated
partial thromboplastin time, international normalized
ratio, and platelet counts were performed. After all
perioperative data were gathered, to maintain homogeneity
of the data and prevent bias, patients with very long
cardiopulmonary bypass (CPB) times (>100 min),
coagulation test abnormalities, and urgent and emergent
procedures and patients who underwent reexploration
for hemorrhage with surgical bleeding sites of other than
sternal origin were excluded from the study. After that, 47
patients remained in the first group, whereas 53 remained
in the second group and 42 in the third group. Drainage
amounts were noted at the postoperative 1st, 2nd, 3rd, 6th,
12th and 24th hours. The amount of units of blood and its
products used were also studied.
All patients were operated on-pump with
administration of heparin, 4 mg/kg, with standard aortic
cross-clamping. The left internal mammary artery was
harvested in each case. Only venous bypass grafts were
used concomitant with the mammary artery. Antegrade,
intermittent crystalloid cardioplegia was administered
from the aortic root and venous bypass grafts. Proximal
anastomoses were performed with single-side clamping.
Bone-wax was spread by digital pressure on the sternal
surfaces immediately after sternotomy and before closing
the chest. ORC was cut and laid along the sternotomy over
the intramedullary area before closing the chest (Figure).
The activated coagulation time levels were measured

Figure. Oxidized regenerated cellulose was cut and laid along the
sternotomy over the intramedullary area before closing the chest.
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and adjusted between 100 and 120 s postoperatively. All
patients received prophylactic systemic antibiotic therapy
(Cefazolin Na, 3 g/day). Salicylic acid or clopidogrel
was begun on the postoperative second day if adequate
hemostasis was achieved and no further bleeding was
expected.
2.1. Statistical analyses
Statistical analyses were performed using SPSS 17.0 for
Windows (SPSS Inc., Chicago, IL, USA). Continuous
variables were expressed as mean values ± standard
deviation (SD). Categorical variables were expressed as
numbers and percentages. Categorical variables were
compared using the chi-square test. For comparison of
continuous variables, the Kruskal–Wallis test was used.
In cases of significant difference the Bonferroni adjusted
Mann–Whitney U test was used to explore the more
efficient group. Statistical significance was set at P < 0.05.
3. Results
There were 142 patients included in the study. The mean
age of the patients was 64.23 ± 5.81 years in the whole
study group. The mean age of the patients was higher in
the third group compared to first and second groups (P =
0.015). There were 114 (79.7%) male patients. There were
no statistically significant differences between the groups
regarding preoperative demographic characteristics (Table
1). The CPB times and mean number of grafts anastomosed
did not differ between the groups.
When the amount of postoperative hemorrhage (mL)
was explored, in the 1st, 2nd, 3rd and 24th hours, the
drainage amount was the lowest in the second group, and
it was lower in the first group compared to third group.
In the 6th and 12th hours, the drainage was again the
lowest in the second group, but there was not a statistically
significant difference between the first and third groups
(Table 2).
The number of fresh frozen plasma and erythrocyte
suspensions used was lowest in the second group, but
there were not statistically significant differences between
the first and third groups (Table 2).
No superficial wound infections (postoperative 30day period) were observed throughout the study period.
Reexploration for hemorrhage due to sternal bleeding
sites was performed only in the electrocauterization alone
group in 3 cases and in none in the other 2 groups (P =
0.026).
4. Discussion
The issue of hemostasis has been widely studied in all
kinds of surgery and numerous hemostatic agents and
agents preventing bleeding have been used. A hemostatic
agent is defined as one intending to produce hemostasis by
accelerating blood coagulation (4). Apart from the hemostatic
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Table 1. Comparison of the 3 groups by preoperative and intraoperative variables.
Bone wax + EC
Mean ± SD

ORC + EC
Mean ± SD

EC
Mean ± SD

P-value*

63.28 ± 6.48

63.36 ± 5.08

66.38 ± 5.43

0.015

BMI (kg/m )

28.00 ± 2.98

28.96 ± 2.89

28.26 ± 2.97

0.242

LVEF (%)

44.00 ± 2.98

42.51 ± 4.81

42.29 ± 4.86

0.119

CPB time (min)

85.96 ± 24.64

90.57 ± 22.31

81.19 ± 21.20

0.141

3.11 ± 0.84

3.09 ± 0.74

3.17 ± 0.66

0.888

n (%)

n (%)

n (%)

P-value**

Patient total

47 (100.0)

53 (100.0)

42 (100.0)

Male sex

37 (78.7)

41 (77.4)

36 (85.7)

0.565

Diabetes mellitus

21 (44.7)

22 (41.5)

15 (35.7)

0.686

Hypertension

32 (68.1)

33 (62.3)

31 (73.8)

0.488

16 (34.0)

21 (39.6)

17 (40.5)

0.786

10 (21.3)

12 (22.6)

12 (28.6)

0.695

2 (4.3)

3 (5.8)

4 (9.8)

0.056

-

5 (9.4)

1 (2.4)

0.05

9 (19.1)

11 (20.8)

12 (28.6)

0.527

Factor
Age
2

Graft #

Dyslipidemia
Peripheral arterial disease

a

Renal dysfunction
Hepatic dysfunction
COPD/asthma

*: Kruskal–Wallis test, **: chi-square test.
: History of therapeutic vascular intervention, history of claudication, or angiography/noninvasive proven peripheral arterial disease.
EC: electrocauterization, ORC: oxidized regenerated cellulose, BMI: body mass index, LVEF: left ventricular ejection fraction, CPB:
cardiopulmonary bypass, COPD: chronic obstructive pulmonary disease.

a

Table 2. Comparison of the 3 groups by postoperative variables.
Drainage

Bone wax + EC
Mean ± SD

ORC + EC
Mean ± SD

EC
Mean ± SD

P-value*

1 hour (mL)

138.83 ± 77.99

99.25 ± 36.45

194.79 ± 51.98

<0.001

2 hours (mL)

213.30 ± 103.76

131.04 ± 39.41

307.17 ± 151.97

<0.001

3 hours (mL)

252.34 ± 57.93

191.06 ± 39.84

293.86 ± 91.52

<0.001

6 hours (mL)

352.94 ± 67.71

243.92 ± 42.26

375.71 ± 113.46

<0.001

12 hours (mL)

477.36 ± 83.71

287.43 ± 40.26

472.17 ± 139.72

<0.001

24 hours (mL)

622.15 ± 102.71

353.00 ± 49.48

695.88 ± 199.98

<0.001

FFP used

1.87 ± 0.76

1.60 ± 0.49

2.52 ± 0.55

<0.001

ES used

2.62 ± 0.61

1.62 ± 0.59

2.83 ± 0.49

<0.001

n (%)

n (%)

n (%)

P-value**

47(100.0)

53 (100.0)

42 (100.0)

-

-

3 (7.1)

Patient total
Reexploration for hemorrhage

0.026

*: Kruskal-Wallis test, **: chi-square test.
EC: electrocauterization, ORC: oxidized regenerated cellulose, FFP: fresh frozen plasma, ES: erythrocyte suspension.
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effect, some also have wound healing and antiinfective
properties (5). In this context, bone wax may be considered
as an agent physically preventing bleeding; oxidized cellulose
and electrocauterization are hemostatic agents.
Electrocauterization (unipolar or bipolar) is a popular
method in terms of preventing surgical bleeding. It is
generally used for soft and adipose tissues. Although
electrocauterization is very effective on the soft tissue, it
is ineffective on the bone tissue. Bipolar cautery is most
frequently used for coagulation of the small vessels and
has minimal efficacy on diffuse capillary bleeding, as in
the case of sternal intramedullary bleeding.
Profuse bleeding from the sternal marrow after
sternotomy is routinely controlled with bone wax in many
heart centers. It is effective, cheap, and therefore favorable
(6). However, some constituents of wax material are not
absorbed by spongious tissue and bacterial implantation
may occur. Complications have been reported considering
the bone wax used as a physical barrier to aid hemostasis
on the surface edge of sternum (3). Bone wax may produce
a giant cell reaction, which may subsequently lead to any
form of sarcoma induction in humans and also to a fibrous
reaction that could prevent osteosynthesis (3). It inhibits
osseous fusion and may promote infection formation (6).
Authors conclude that it should be used sparingly and
suggest avoidance of excessive application of bone wax
to prevent sternotomy dehiscence (3,6). Increased risk of
mediastinitis with wax use was reported (3). Bone wax
should not be used excessively and should be avoided
in patients at high risk for infection (6). In particular,
bone wax might not even be effective in elderly patients
and those with osteoporosis. The spongiosa scaffold of
the marrow cavity might absorb large quantities of bone
wax with still enhanced bleeding. Prziborowski et al.
reported that bone wax is not an independent risk factor
concerning early resternotomy, sternum stabilization,
sternal infection, early mortality, and blood and blood
product consumption (7). Conversely, Mair et al. showed
that it inhibits osseous fusion, causes infections, and may
even be responsible for embolization from sternotomy
incisions to the lung (8). We did not encounter any wound
infections or sternal instability due to wax use in our study.
ORC was developed in 1960 and it was manufactured
from wood pulp, which contains about 50% cellulose.
It generates an artificial clot lowering pH and causing a
caustic effect (9). The clot is brownish because it has acid
hematin (10). It has different mechanisms of action. It
creates a physical and a mechanical barrier. It absorbs
serum and expands. It returns to the gelatinous formation.
It activates extrinsic hemostatic pathway and platelets.
The most important advantage of the ORC is definitely its
resistance to the pathogenic organisms in vivo and in vitro
(9). This product is applied topically and can effectively
control diffuse capillary oozing (11).
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Supporting the osteoinductive effect of ORC, Mair et
al. placed ORC strips to the preoperatively existent sternal
fractures in 38 patients with weak sternal bones. None of
the patients required reoperation for bleeding or sternal
instability. They reported that superficial wound infection
developed in 2 patients, who were treated with topical
dressing, and deep sternal wound infections did not occur
(8).
It is different from the bone wax because it is absorbed
(11). Since it is a chemically altered form of cellulose, it
is first dissolved and then turned into a continuous fiber
(12). It is supplied as a knitted strip that can be easily
trimmed to any size. It swells and expands to the sternal
corpus. One major advantage of oxidized cellulose over
wax is its definite and potent action against a wide variety
of pathogenic organisms, both in vivo and in vitro. This
beneficial effect is immediate and is exerted by a low pH
effect. The current theory is that this chemical hemostasis
reduces the effective initial inoculum with an acid hostile
ambient, allowing the host’s natural defenses to overcome
the organism (13). It has also been shown to reduce
Staphylococcus aureus growth in in vitro set-ups (14).
For comparison of wax and ORC, Finn et al., in an
experimental study, produced surgical defects in the iliac
crests of 4 dogs. Bone wax caused a marked foreign-body
reaction and lack of bone reformation. They concluded that
ORC might be adequately used in iliac bone procurement,
whereas wax seemed to be contraindicated (15).
The present study clearly demonstrates that ORC
decreases sternal intramedullary bleeding and does not
increase the infection rates. The reexploration rates were
also shown to be decreased with ORC use. When the
number of fresh frozen plasma and erythrocyte suspensions
used were studied, the requirements were lowest in the
ORC group compared to others. However, there are many
factors affecting postoperative blood and its products use,
and those many parameters were not taken into account
during the study, so any conclusion related with this subject
derived from these data could not be made.
In conclusion, hemorrhage originating from the sternal
intramedullary space may cause too much blood loss,
which may or may not necessitate revision. To overcome
this undesired complication, ORC concomitant with
electrocauterization can be used safely immediately before
closing the chest in open heart surgery.
Although the exact origin of bleeding cannot be
determined unless revision is not required due to excessive
blood loss, the homogeneity of the data was maintained
to overcome bias. Cost analysis was not made during the
study, which could have reflected the cost-effectiveness of
ORC use more objectively. Additionally, regarding the use
of blood and its products, more variables should be taken
into account.
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